AAAAAA

   
Results: 1-3 |
Results: 3
TARGETING INDIVIDUALS AT HIGH-RISK FOR ISCHEMIC-HEART-DISEASE - WHAT COULD WE BENEFIT FROM MEASURING FASTING INSULIN, APOLIPOPROTEIN-B AND LDL PARTICLE-SIZE
Authors: LAMARCHE B TCHERNOF A MAURIEGE P CANTIN B DAGENAIS G LUPIEN P DESPRES JP
Citation: B. Lamarche et al., TARGETING INDIVIDUALS AT HIGH-RISK FOR ISCHEMIC-HEART-DISEASE - WHAT COULD WE BENEFIT FROM MEASURING FASTING INSULIN, APOLIPOPROTEIN-B AND LDL PARTICLE-SIZE, Diabetes, 46, 1997, pp. 173-173
THE LOW-DENSITY-LIPOPROTEIN RECEPTOR IS NOT REQUIRED FOR NORMAL CATABOLISM OF LP(A) IN HUMANS
Authors: RADER DJ MANN WA CAIN W KRAFT HG USHER D ZECH LA HOEG JM DAVIGNON J LUPIEN P GROSSMAN M WILSON JM BREWER HB
Citation: Dj. Rader et al., THE LOW-DENSITY-LIPOPROTEIN RECEPTOR IS NOT REQUIRED FOR NORMAL CATABOLISM OF LP(A) IN HUMANS, The Journal of clinical investigation, 95(3), 1995, pp. 1403-1408
MUTATIONS OF LOW-DENSITY-LIPOPROTEIN-RECEPTOR GENE, VARIATION IN PLASMA-CHOLESTEROL, AND EXPRESSION OF CORONARY HEART-DISEASE IN HOMOZYGOUSFAMILIAL HYPERCHOLESTEROLEMIA
Authors: MOORJANI S ROY M TORRES A BETARD C GAGNE C LAMBERT M BRUN D DAVIGNON J LUPIEN P
Citation: S. Moorjani et al., MUTATIONS OF LOW-DENSITY-LIPOPROTEIN-RECEPTOR GENE, VARIATION IN PLASMA-CHOLESTEROL, AND EXPRESSION OF CORONARY HEART-DISEASE IN HOMOZYGOUSFAMILIAL HYPERCHOLESTEROLEMIA, Lancet, 341(8856), 1993, pp. 1303-1306
Risultati: 1-3 |